SUMMARY The renal effects of frusemide treatment in infants with respiratory distress syndrome shortly after birth and during the first three postnatal days were evaluated. Eighty five infants were randomly assigned to two groups. Forty two received three doses of intravenous frusemide (1 mg/kg) starting at age, mean (SD) 7-5 (4-1) 
Frusemide has been used in neonates with respiratory distress syndrome at various postnatal ages with conflicting results,' 2 but our previous controlled study indicated that very early use of this drug is beneficial.3 Although the elfectiveness of frusemide on fluid and eletrolytes balance has been well documented in slightly older infants, this information is lacking in neonates. In preterm infants with respiratory distress syndrome, many of the humoral factors, for example aldosterone and vasopressin concentrations, may be increased4 5 shortly after birth and their renal response to frusemide may be altered. The present study was conducted to evaluate the renal effects of frusemide shortly after birth and during the first three postnatal days in infants with respiratory distress syndrome.
Materials and methods
The study was During the study period fluid intake was adjusted to 80, 95, and 110 ml/kg per day on the first, second, and third postnatal days respectively. An additional 20 ml/kg per day was given if the infants were receiving phototherapy. The intravenous fluids consisted of a 5 to 10% dextrose with sodium (25 mmol/l), potassium (20 mmol/l), and calcium (200 mg/kg per day calcium gluconate). No oral or nasogastric feeding was administered during the study period.
Using the U bags (Hollister, Chicago), urine collections were obtained for osmolality and electrolytes analyses in four aliquots; 0 to 12, 12 to 24, 24 to 48, and 48 to 72 hours after entry into study. Suprapubic compression was performed at the beginning and end of each collection to make sure that the bladder was empty. During the study, all infants were kept inside their incubators and their skin temperatures were maintained by servocontrol at 36 5°C.
Serum and urinary sodium and potassium concentrations were determined with a flame spectrophotometer, serum and urinary chloride concentrations with a chloridometer, serum blood urea nitrogen (BUN) by enzymatic conductivity with a Beckman BUN Analyzer, and serum and urinary creatinine by the Jaffe alkaline picrate method. Osmolality of serum and urine were determined by the freezing point method with an osmometer (Advanced Digimatic Osmometer, Model 3D II).
The following indices were determined: (1) creatinine clearance corrected for surface area according to the formula of Haycock et al;8 (2) fractional excretion of filtered sodium (FENa), chloride (FEcl), and potassium (FEK) using the conventional formula; eg FENa=(U/S Na)/(U/S Cr) x 100; where U/S Na=urinary sodium (mmol/l)/serum sodium (mmol/l), and U/S Cr=urinary creatinine (mmol/l)/serum creatinine (mmol/l); (3) osmolar clearance (Cosm) using the equation The data from the study periods were compared between the groups using independent Student's t test and within the group using dependent Student's t test. The x2 test was used to compare the groups with respect to categorical variables. The values were expressed as mean (SD). Except where otherwise indicated the time specified in the text was the time or period after entry into the study.
Results
Pertinent clinical data for the two groups are shown in Table 1 . There was no significant difference between the two groups in respect of gestational age, birthweight, and pulmonary status at the time of entry into the study. The postnatal age was 7X2 (4.0) hours for the control group and 7X5 (4-1) hours for the study group. Tables 2 and 3 provide the data on all variables assessed during the study.
Serum electrolytes, blood urea nitrogen, creatinine, and osmolality (Table 2 ). The baseline values of serum electrolytes, blood urea nitrogen, creatinine, and osmolality were comparable between the groups. Both groups of infants had significant (P<0-01) increases in serum sodium from their baseline values by 24 hours after entry into the study, but there were no significant differences between the groups at any time during the study. Serum chloride increased in the control group at 24 Conversion-SI to traditional units: I kPa7-5 mmHg.
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and 72 hours but remained unchanged in the study group. A significant difference in serum chloride between the groups was seen at 24, 48, and 72 hours. The serum potassium remained unchanged in both groups and did not show any significant difference between the groups during the study. Both groups of infants had significant increases in serum blood urea nitrogen and osmolality but no significant difference was seen between the groups at any time during the study. While there was no significant change in serum creatinine in the control group, significant increases were seen in the study group at 24, 48, and 72 hours and these were higher than the respective values of the control infants.
Glomerular filtration rate, urine output ( Both groups of infants lost weight during the study (1.7%, 5*4%, 8-3% of birthweight in the control and 2-5%, 6-6%, and 10-3% of birthweight in the study group at 24, 48, and 72 hours respectively) but a statistically significant difference between the groups was seen only at 72 hours.
Fractional excretion of filtered electrolytes ( Table 3 ).
The baseline values of FENa, FEci at 0 to 12 hours in the frusemide group were already higher than in the control group; they remained unchanged and were higher than in the control group throughout the study period. Significant increases in FENa from the baseline were also seen in the control infants at 12 to 24, 24 to 48, and 48 to 72 hours. The urinary FEK was higher in the study group than in the control group but the differences between the groups failed to reach a statistical significance.
Osmolar and free water clearance. (Table 3) . The values of osmolar clearance at 0 to 12 and 12 to 24 hours in the study group were higher than in the controls. In the control group, a significant increase in osmolar clearance was seen at 24 to 48 and 48 to 72 hours; their values were comparable to those of the study group. The free water clearance remained unchanged in both groups and did not show any significant difference between the groups during the study.
Serum and urinary calcium concentrations. Based on the data obtained from 32 infants (17 control, 15 study), in which serum and urinary calcium were measured, infants in the study group had significantly (P<0.05) higher calcium excretion than infants in the control group at 24 to 48 hours (0.37 (0.05) mmol/l v 0-15 (0-07) mmol/l) and 48 to 72 hours (0-6 (0-1) mmol/l v 0-2 (0-12) mmol/l) after entry into study. There was, however, no significant difference between groups' serum calcium concentrations at any time during the study. (Table 2 ).
Perinatal hypoxia and renal response to frusemide. Since perinatal hypoxia may play an important role in renal function and renal response to frusemide, the infants were divided into two groups based on their Apgar scores measured one minute after birth. The data were analysed and the statistical significances between the groups are shown in Table 4 . The results can be summarised as follows: (1) within the study group, infants with an Apgar score greater than 3 had better diuretic response than those whose scores was 3 or less; (2) in the control group, infants with an Apgar score of greater than 3 had higher urine output and a higher glomerular filtration rate than infants whose score was 3 or less at 48 to 72 hours after entry into study; (3) for those infants with an Apgar score greater than 3, frusemide significantly enhanced the urine output and sodium excretion compared with control infants; (4) for those infants with Apgar score of 3 or less, frusemide did not enhance urine output, but it did, to some extent, enhance sodium excretion compared with control infants. From these data it seems that: (1) perinatal hypoxia not only affects the urine output in the control infants but also affects the diuretic response to frusemide in the treated infants; (2) perinatal hypoxia has little effect on sodium excretion in the control infants and on natriuretic response in the study group.
Discussion
This study indicates that a spontaneous increase in urine output occurred at 48 to 72 hours and in urinary sodium and chloride excretion at 12 to 24, 24 to 48, and 48 to 72 hours after entry into the study (7-2 (4-0) hours postnatal age) in infants with respiratory distress syndrome. The use of frusemide enhances sodium and chloride excretion at 0 to 12, 12 to 24, 24 to 48, and 48 to 72 hours and urine output at 24 to 48 and 48 to 72 hours after beginning treatment (7-5 (4-1) hours). The inadequate diuretic response to frusemide within 24 hours of frusemide treatment may be related to perinatal hypoxia. Frusemide has been the diuretic of choice in newborn infants. This drug inhibits active chloride reabsorption from the ascending limb of the loop of Henle, resulting in a decrease in passive sodium reabsorbtion and diuresis.9 Frusemide stimulates the renal synthesis of prostaglandins, particularly prostaglandin E2, which may mediate the haemodynamic and tubular effects of the kidney.10 1'
Frusemide has also been shown to have an antivasopressin effect on the distal tubules.'2 In addition, frusemide produces systemic vascular effects that are independent of its diuretic action.13 14 Several studies carried out in the late neonatal period showed that frusemide produced increases in urine flow rates and sodium, potassium, and calcium excretion.2 15 The effects of frusemide on fluid and electrolytes balance have not been well studied in critically ill preterm infants shortly after birth. Infants with respiratory distress syndrome have raised renin, angiotensin, aldosterone, and circulatory prostaglandins values early in their postnatal life'&8 that may affect the fluid and electrolyte balance during frusemide treatment.
It is clear from this study that frusemide induces saluresis very early in postnatal life. This effect was observed even in infants with very low Apgar scores. It is also interesting to observe that, in spite of saluresis, the serum sodium concentration was Thus, the diuretic effect of frusemide could be antagonised by vasopressin in hypoxia. Furthermore, the serum osmolality (Table 2 ) and urine osmolality (181 and 206 mmol/kg in the control and study groups respectively) were already high on the first postnatal day, indicating a degree of dehydration. While infants are dehydrated, vasopressin release may be stimulated and noticeable water diuresis may not occur. Since the diuretic response of frusemide depends on the fraction of the administered dose that reaches the renal tubule lumen, it is possible that the amount of frusemide in the tubule was not adequate because of a low glomerular filtration rate and low tubular secretion, both of which may occur during perinatal hypoxia.21 Alternatively, it is also possible that the dosage of frusemide was not adequate or the renal tubules were not sensitive to it because of immaturity. We did not measure the concentrations of frusemide in serum and urine and do not know if larger dosage would achieve diuresis. From this study, it seems that perinatal hypoxia and a low glomerular filtration rate are responsible for the lack of diuresis early in postnatal life.
In summary, this study indicates that small preterm infants with respiratory distress syndrome may not achieve a diuretic response to frusemide shortly after birth. Perinatal hypoxia and dehydration may be the important factors responsible for this lack of diuresis. Natriuresis and chloruresis occurred effectively shortly after frusemide administration and did not seem to be affected by perinatal hypoxia. The mechanisms remain unknown. The results of this study provide useful information for further investigation. 
